Latest Strategic Refocus News

Frontier Digital Ventures reported a sharp 18% revenue decline in FY2025 due to shedding low-margin businesses, yet achieved a remarkable 205% jump in EBITDA, signalling a successful pivot to core classifieds in emerging markets.

Clara Resources pivots exclusively to its Mareeba Gold Project in North Queensland, securing $1.1 million in fresh capital and renewing its board to drive exploration in a historically rich but underexplored gold province.

Aeris Resources has finalised the sale of its North Queensland copper assets to Dingo Minerals, unlocking immediate cash and environmental bond releases with further payments contingent on production milestones.

Alchemy Resources has agreed to sell its Karonie and Lake Rebecca gold projects to Forrestania Resources for $5 million in shares, while retaining a 1% royalty. This deal marks a strategic refocus on Alchemy’s promising New South Wales assets.

ActivEX Limited has fully repaid its $2.3 million loan to Star Diamond Developments by transferring full ownership of its East Coast Gold and Copper subsidiary, leaving the company debt free and financially strengthened.

Kingfisher Mining has agreed to sell its Gascoyne rare earth elements project to Dreadnought Resources for $2 million in shares plus milestone payments, freeing capital to advance its copper-gold portfolio in New South Wales.

Opthea Limited reports a striking turnaround with a $339.9 million profit for H1 2026, driven by a strategic refocus on developing OPT-302 for Lymphangioleiomyomatosis (LAM), a rare lung disease affecting women. The company plans a rebrand and ASX reinstatement as it charts a new course in rare respiratory health.

Nexion Group Ltd reports a striking turnaround to a $6.3 million net profit in H1 2026, driven by gains from subsidiary sales, while continuing operations still face losses amid efforts to regain ASX trading status.

HALO Technologies reports a strategic pivot towards APAC growth and a UK business model overhaul, alongside a 16% revenue decline and increased net loss in FY25.

Epsilon Healthcare Limited has reported a robust recovery in 2025, with revenue climbing 68% to $9.39 million and net losses shrinking by 63%, driven by growth in contract manufacturing and a new pharmacy division.

Percheron Therapeutics reports a 64% reduction in half-year losses to $3.1 million, driven by progress in its licensed immuno-oncology drug HMBD-002 and a strategic pivot away from discontinued assets.

Energy World Corporation has eliminated all group-level borrowings, strengthening its balance sheet and advancing key LNG and power projects in Southeast Asia amid ongoing operational losses.